Clinical trial Recruiting at 1 site Interventional Ages 18 to 65 Women only

Serratus vs Erector Spinae Block for Pain After Unilateral Breast Surgery

Official title: Comparison of Serratus Posterior Superior Intercostal Plane Block and Erector Spinae Plane Block for the Prevention of Chronic Postoperative Pain After Unilateral Breast Surgery: A Prospective, Randomized, Assessor-Blinded Trial

Run by Kocaeli City Hospital · NCT07674836 · Data updated 2026-11-12

This trial tests whether serratus posterior superior intercostal plane block or erector spinae plane block reduces chronic pain 3 months after unilateral breast surgery in adult women.

More Opioid Use trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexWomen only
Enrollment90 (estimated)
SponsorKocaeli City Hospital
Government
Locations1 site (İzmit, Kocaeli)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedSeptember 30, 2026
Trial IDNCT07674836 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18-65 undergoing elective unilateral breast surgery, with ASA I-III, BMI 18-35, and no contraindications to regional anesthesia.

Probably not a fit

Patients who do not experience pain reduction, have intraoperative complications, require additional intraoperative analgesia outside the protocol, or have a failed block may not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, assessor-blinded study in adult women undergoing elective unilateral breast surgery. Participants will be assigned 1:1 to receive either a serratus posterior superior intercostal plane block or an ultrasound-guided erector spinae plane block before general anesthesia. The primary outcome is chronic postoperative pain at 3 months, measured with the Brief Pain Inventory-Short Form. The study aims to determine if one regional technique leads to less chronic pain than the other. Standard perioperative care will be followed, and all data will be analyzed to compare long-term pain outcomes between groups.

Why it matters

Potential benefit: If successful, the preferred block could reduce chronic postoperative pain and opioid needs after unilateral breast surgery.

How similar studies have gone: Prior research has explored regional blocks for breast surgery, with mixed results; this study adds a direct comparison of two blocks with attention to long-term pain.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients aged 18-65 years
* ASA physical status I-III
* Body mass index (BMI) between 18 and 35 kg/m²
* Scheduled for elective unilateral breast surgery (mastectomy with or without sentinel lymph node biopsy)
* Ability to understand and provide written informed consent

Exclusion Criteria:

* Infection at the site of block application
* Known allergy to local anesthetics
* Coagulopathy or anticoagulant therapy
* Chronic opioid use
* Pregnancy
* Inability to communicate or cooperate
* Refusal to participate
* Failed block
* Requirement of additional intraoperative analgesia outside the study protocol
* Development of serious intraoperative complications

Where it's running

  • University of Health Sciences Kocaeli City Hospital
    İzmit, Kocaeli, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.